What is the risk of CHF and CV death associated with the use of pioglitazone?

MOspace/Manakin Repository

Breadcrumbs Navigation

What is the risk of CHF and CV death associated with the use of pioglitazone?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/7590

[+] show full item record


Title: What is the risk of CHF and CV death associated with the use of pioglitazone?
Author: Jewison, David; Merok, Joshua R.
Keywords: type 2 diabetes
Date: 2009-10
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 12(10): 11-12.
Series/Report no.: Help Desk Answers
Abstract: Pioglitazone use may be associated with a small (<2%) increased risk of nonfatal heart failure. (SOR B, based on heterogenous meta-analyses.) There is no adverse effect on cardiovascular death rates. (SOR A, based on consistent meta-analyses.)
URI: http://hdl.handle.net/10355/7590

This item appears in the following Collection(s)

[+] show full item record